(194 days)
Not Found
No
The device description details a purely mechanical and magnetic mechanism for adjusting pressure settings. There is no mention of algorithms, learning, or data processing that would indicate AI/ML.
Yes
The device is used to manage hydrocephalus by providing constant intraventricular pressure and drainage of cerebrospinal fluid (CSF), which qualifies it as a therapeutic device.
No
Explanation: The device is an implantable shunt system designed to treat hydrocephalus by regulating intraventricular pressure and draining cerebrospinal fluid, not to diagnose a condition.
No
The device description clearly details a physical, implantable device with mechanical components (valve, spring, cam, pivot) and a magnetic programming mechanism, indicating it is hardware-based.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the management of hydrocephalus by providing constant intraventricular pressure and drainage of cerebrospinal fluid. This is a therapeutic and physiological function within the body.
- Device Description: The description details an implantable mechanical device designed to regulate fluid pressure and flow within the brain. It does not involve the examination of specimens derived from the human body for the purpose of providing information for diagnosis, monitoring, or compatibility.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, CSF for analysis, etc.), reagents, or any process related to in vitro testing.
Therefore, the HP Valve System is a medical device, specifically an implantable shunt, but it does not fit the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The HP Valve System is an implantable device that provides constant intraventricular pressure and drainage of cerebrospinal fluid (CSF) for the management of hydrocephalus.
Product codes
JXG
Device Description
The HP Valve System is a hydrocephalus shunt designed to allow the surgeon to change the valve operating pressure without surgical intervention. Intraventricular pressure is maintained at a constant level by the device's rubyball-in-cone valve seat design. The center of a flat spring is attached to a fixed fulcrum, with one end resting on the ruby ball and the other end resting on an eighteen position spiral staircase shaped cam that rotates on a titanium pivot. When the cam rotates the tension on the spring changes as the distal end of the spring moves up or down the cam. The operating pressure of the valve is thereby adjusted. During programming, the programmer transmits a coded magnetic signal to the device, causing the cam to rotate. The device has 18 pressure settings, ranging from 30mm to 200mm H20, in 10mm increments.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
| Testing Performed | Comments |
|---|---|
| Biocompatibility Testing | Biocompatibility tests were performed per the Tripartite Biocompatibility Guidance for Medical Devices and ISO 10993 Biological Testing of Medical and Dental Materials and Devices. Testing results demonstrated that the device materials are biocompatible. |
| Performance Testing | Performance testing was conducted per and complies with the applicable sections of ASTM F647-94 - Standard Practice for Evaluating and Specifying Impantable Shunt Assemblies for Neurosurgical Applications. Performance testing included the following areas; Reprogramming, Fatigue, Corrosion, MRI, Wet Pressure and Programmer Evaluation. Testing results demonstrated the suitability of the device for its intended use. |
| Clinical Evaluation | A controlled, randomized, clinical trial was conducted to support a claim of substantial equivalence. 377 patients were enrolled and followed for two years. Results indicated that the HP Valve System performs as well as and is as safe and effective as currently marketed hydrocephalus shunt systems. |
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.5550 Central nervous system fluid shunt and components.
(a)
Identification. A central nervous system fluid shunt is a device or combination of devices used to divert fluid from the brain or other part of the central nervous system to an internal delivery site or an external receptacle for the purpose of relieving elevated intracranial pressure or fluid volume (e.g., due to hydrocephalus). Components of a central nervous system shunt include catheters, valved catheters, valves, connectors, and other accessory components intended to facilitate use of the shunt or evaluation of a patient with a shunt.(b)
Classification. Class II (performance standards).
0
EXHIBIT I
510K Summary HP Valve System December 18, 1997
Submitter 1.
1 1998
Johnson & Johnson Professional, Inc. 325 Paramount Drive Raynham, MA 02767 Diane Minear, Senior Regulatory Consultant, (508) 828-3532
Device Name 2.
| Proprietary Name: | HP Valve System |
|---|---|
| Common Name: | Hydrocephalus Shunt |
| Classification Name: | Central Nervous System Fluid Shunt and Components |
| Regulatory Class: | Class II by 21 CFR §882.5550 |
3. Intended Use
The HP Valve System is an implantable device that provides constant intraventricular pressure and drainage of cerebrospinal fluid (CSF) for the management of hydrocephalus.
4. Device Description
The HP Valve System is a hydrocephalus shunt designed to allow the surgeon to change the valve operating pressure without surgical intervention. Intraventricular pressure is maintained at a constant level by the device's rubyball-in-cone valve seat design. The center of a flat spring is attached to a fixed fulcrum, with one end resting on the ruby ball and the other end resting on an eighteen position spiral staircase shaped cam that rotates on a titanium pivot. When the cam rotates the tension on the spring changes as the distal end of the spring moves up or down the cam. The operating pressure of the valve is thereby adjusted. During programming, the programmer transmits a coded magnetic signal to the device, causing the cam to rotate. The device has 18 pressure settings, ranging from 30mm to 200mm H20, in 10mm increments.
1
Predicate Device Comparison 5.
The HP Valve System is substantially equivalent in terms of intended use, materials, design, manufacturing, and function to the HAKIM Precision Valve System (K944222). Both devices utilize the same ball-in-cone valve mechanism to maintain intraventricular pressure. The valve design maintains intraventricular pressure at a constant selected level. Depending on the CSF flow rate and/or viscosity, the ball moves up or down within the cone under the control of the calibrated flat stainless steel spring. The cross section of the valve through which CSF flows automatically increases or decreases, therefore maintaining the selected pressure.
While the pressure regulating mechanism is identical in both devices, the variable pressure setting feature is only available with the HP Valve System, while the HAKIM Precision Valve System is available in five fixed pressure ranges.
Device Testing Summary હે.
| Testing Performed | Comments |
|---|---|
| Biocompatibility | |
| Testing | Biocompatibility tests were performed per the Tripartite |
| Biocompatibility Guidance for Medical Devices and ISO 10993 | |
| Biological Testing of Medical and Dental Materials and | |
| Devices. Testing results demonstrated that the device | |
| materials are biocompatible. | |
| Performance Testing | Performance testing was conducted per and complies with the |
| applicable sections of ASTM F647-94 - Standard Practice for | |
| Evaluating and Specifying Impantable Shunt Assemblies for | |
| Neurosurgical Applications. Performance testing included the | |
| following areas; Reprogramming, Fatigue, Corrosion, MRI, Wet Pressure and Programmer Evaluation. Testing results | |
| demonstrated the suitability of the device for its intended use. | |
| Clinical Evaluation | A controlled, randomized, clinical trial was conducted to |
| support a claim of substantial equivalence. 377 patients were | |
| enrolled and followed for two years. Results indicated that the | |
| HP Valve System performs as well as and is as safe and | |
| effective as currently marketed hydrocephalus shunt systems. |
2
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 1 1998
Ms. Diane Minear ·Senior Regulatory Consultant Johnson & Johnson Professional, Inc. 325 Paramount Drive Raynham, Massachusetts 02767-0350
Re: K974739 Trade Name: Hakim Programmable Valve System Regulatory Class: II Product Code: JXG Dated: June 24, 1998 Received: June 25, 1998
Dear Ms. Minear:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 - Ms. Minear
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Celia M. Witten, Ph.D., M.D.
Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
HAKIM PROGRAMMABLE VALVE SYSTEM Indications For Use
1